Advanced search×

Lack of perceived sleep improvement after 4-month structured exercise programs.

Menopause 14(3 Pt 1):535-40 (2007) PMID 17224851

Many middle-aged women experience decreases in their sleep quality during the menopausal transition. Physical activity has been shown to improve sleep, but few randomized, controlled trials investigating such effects in this population exist. In 164 previously low-active middle-aged women (mean age = 49.9, SD = 3.6), using a 4-month randomized, controlled trial, we examined structured exercise in the form of walking or yoga to determine the effects on perceived sleep quality.

DOI: 10.1097/01.gme.0000243568.70946.d4
Version: za2963e q8za6 q8zb2 q8zcc q8zd2 q8ze6 q8zf8 q8zg2

Similar articles you may find interesting…

  1. Postoperative improvement in acoustic rhinometry measurements after septoplasty correlates with long-term satisfaction.

    Rhinology 51(2):171-5 (2013) PMID 23671898

    Our goal was to compare pre- and postoperative acoustic rhinometry measurements with satisfaction 11 years after surgery. Acoustic rhinometry measurements were performed preoperatively and 3 months postoperatively. Satisfaction was evaluated with semi-structured interviews by telepho...
  2. Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous h...

    J Clin Med Res 5(3):174-84 (2013) PMID 23671543

    Standard therapy for multiple myeloma (MM) includes initial autologous hematopoietic cell transplantation (autoHCT1) but this is not curative and most patients will relapse. Role of salvage autoHCT2 or allogeneic HCT (alloHCT2) is undefined. MM patients who relapsed a...
  3. Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for r...

    J Med Econ (2013) PMID 23647445

    Results of the EPOC study are anticipated in early 2013 and will inform treatment selection by providing patient-centered data on therapy switch to fingolimod or standard-of-care DMTs. Trial Registration: ClinicalTrials.gov NCT01216072....